AIAnthropic's Claude Agents Discover Novel CRISPR-Like Enzyme System (ART)
Anthropic announced Claude running ~950 agents autonomously identified ART (array-associated reverse transcriptases)—a previously uncharacterized enzyme system in bacteriophages. The company's Bay Area wet lab validated key aspects, marking the first major output from Anthropic's life sciences group.
TLDR
This demonstrates AI agents performing genuine scientific discovery at scale, compressing work that typically takes humans weeks or months. It fuels excitement about AI-accelerated drug discovery and biology research while raising questions about the pace of AI capability advancement. CRISPR pioneer Feng Zhang called it "genuinely intriguing," and the discovery aligns with broader enthusiasm for AI in biomedical progress, though the enzyme's practical function and biotech utility remain unproven.
Anthropic's Claude Agents Discover Novel CRISPR-Like Enzyme System (ART)
Anthropic announced Claude running ~950 agents autonomously identified ART (array-associated reverse transcriptases)—a previously uncharacterized enzyme system in bacteriophages. The company's Bay Area wet lab validated key aspects, marking the first major output from Anthropic's life sciences group.
TLDR
This demonstrates AI agents performing genuine scientific discovery at scale, compressing work that typically takes humans weeks or months. It fuels excitement about AI-accelerated drug discovery and biology research while raising questions about the pace of AI capability advancement. CRISPR pioneer Feng Zhang called it "genuinely intriguing," and the discovery aligns with broader enthusiasm for AI in biomedical progress, though the enzyme's practical function and biotech utility remain unproven.
